We searched Medline using the medical subject heading (MeSH) terms “coeliac disease” and “celiac disease” for articles published between January, 1998, and January, 2009, but did not exclude commonly referenced and highly regarded older publications. We also searched the reference lists of review articles on coeliac disease.
SeminarCoeliac disease
Introduction
Coeliac disease is a chronic inflammatory disease characterised by flattened villi on the small bowel mucosa, and is induced in genetically susceptible people by the ingestion of proline-rich and glutamine-rich proteins in wheat, rye, and barley. Researchers postulate that the condition first developed after the last ice age in the fertile crescent of the Middle East with the cultivation of grains, and the first description dates from the 1st and 2nd centuries CE.1 Coeliac disease has a diverse clinical heterogeneity, and increases both morbidity and mortality. However, knowledge of many aspects of this disorder is inadequate—even in the academic specialty setting.2
Section snippets
Epidemiology
The accuracy of estimates of the true prevalence of coeliac disease has been substantially improved by the increased reliability of serological tests—namely for IgA antigliadin antibodies, initially, then for antiendomysial antibodies and IgA antihuman tissue transglutaminase (hTTG) antibodies. In large population samples, these tests enable screening for people who need a biopsy to confirm intestinal coeliac lesions. By means of this approach, the prevalence of biopsy-proven coeliac disease in
Causation
Coeliac disease develops as a consequence of the encounter between an environmental trigger and a genetically predisposed host, with the possible participation of other environmental cofactors (figure 1).
Pathophysiology
Study of the pathogenesis of coeliac disease has focused on the mechanisms by which gluten peptides, after crossing the epithelium into the lamina propria, are deamidated by tissue transglutaminase and then presented by DQ2+ or DQ8+ antigen-presenting cells to pathogenic CD4+ T cells. Once activated, the CD4+ T cells drive a T-helper-cell type 1 response that leads to the development of coeliac lesions—namely intraepithelial and lamina propria infiltration of inflammatory cells, crypt
Mode of presentation
Until 30 years ago, the use of intestinal biopsy was reserved for patients with symptoms of overt malabsorption and, consequently, the prevalence of malabsorption among patients with coeliac disease was very high. At the beginning of the 1980s, awareness of the disease improved and a lowered threshold for its investigation led us to acknowledge the more subtle and variable clinical expression of the condition. At the end of the 1980s—after the advent of serology—the number of patients with
Case finding
The burden of undetected disease is very high: a cautious prevalence estimate of 0·5% equates to around 2·5 million patients still undiagnosed in Europe, and researchers have calculated that the ratio between diagnosed and undiagnosed patients is as high as 1:7.89 Increased physician awareness of the clinical range of this disorder and a continued high threshold of suspicion are, therefore, needed. Researchers have shown that case-finding by measurement of antiendomysial antibodies or hTTG
Dietary treatment
The only proven treatment for coeliac disease is strict and life-long adherence to a gluten-free diet. All food and drugs that contain gluten from wheat, rye, barley, and their derivatives must be eliminated because even small amounts can be harmful. Gluten contamination in gluten-free products cannot be completely avoided; results of a double-blind placebo–control trial established that 10 mg gluten per day is tolerated whereas 50 mg is harmful.110 Individual variability between patients,
Complications
Results of studies from Italy121 and Sweden122 showed a twofold increased mortality in patients with coeliac disease, whereas this risk was only marginally raised in the UK.123 The risk of death rose with increasing delay in diagnosis and in patients with poor dietary compliance; non-Hodgkin lymphoma was the main cause of death.121 Patients diagnosed with the condition in childhood have a threefold increased risk of long-term mortality.124 However, this excess was mostly attributable to
Future directions
Improved understanding of the molecular basis of coeliac disease has enabled researchers to suggest alternatives to a gluten-free diet. These novel treatments are aimed at blunting the immune stimulatory effects of gluten (figure 6). However, we emphasise that some of these drugs (tissue-transglutaminase-inhibitors and monoclonal antibodies) have a poor safety profile, and their hypothetical use could, thus, be reserved for complicated forms of the disease.
Alternative approaches to manage the
Search strategy and selection criteria
References (155)
- et al.
A prospective study of the incidence of childhood celiac disease
J Pediatr
(2003) - et al.
Why is coeliac disease endemic in the people of the Sahara?
Lancet
(1999) Chemistry of gluten proteins
Food Microbiol
(2007)- et al.
Wheat peptide challenge in coeliac disease
Lancet
(1994) - et al.
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease
Lancet
(2003) - et al.
Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease
Gastroenterology
(2003) The precipitating factor in coeliac disease
Baillieres Clin Gastroenterol
(1995)- et al.
Gliadin immune reactivity is associated with overt and latent enteropathy in relatives of celiac patients
Gastroenterology
(1992) - et al.
HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease
Hum Immunol
(2003) - et al.
Celiac disease genetics: current concepts and practical applications
Clin Gastroenterol Hepatol
(2005)
Genome search in celiac disease
Am J Hum Genet
Breast-feeding protects against celiac disease
Am J Clin Nutr
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease
Am J Gastroenterol
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease
Gastroenterology
Matrix metalloproteinase pattern in celiac duodenal mucosa
Lab Invest
Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease
Gastroenterology
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease
Gastroenterology
Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease
Gastroenterology
Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease
Gastroenterology
A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease
Immunity
Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease
Gastroenterology
Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation
Gastroenterology
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease
Gastroenterology
Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness
J Autoimmun
Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001
Clin Gastroenterol Hepatol
Characteristics of adult celiac disease in the USA: results of a national survey
Am J Gastroenterol
Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease
Dig Liver Dis
Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment
Clin Gastroenterol Hepatol
Bone mass and metabolism in patients with celiac disease
Gastroenterology
Osteoporosis in adult patients with celiac disease
Bone
A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease
J Pediatr
Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease
Gastroenterology
Coeliac disease and reproductive disorders: a neglected association
Eur J Obstet Gynecol Reprod Biol
Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum
Gastroenterology
Case-finding in coeliac disease should be intensified
Best Pract Res Clin Gastroenterol
How many duodenal biopsy specimens are required to make a diagnosis of celiac disease?
Gastrointest Endosc
Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease
Clin Gastroenterol Hepatol
A history of coeliac disease
Dig Dis
Knowledge of some aspects of celiac sprue among professors of gastroenterology
Int Med J
Prevalence of celiac disease among children in Finland
N Engl J Med
Mass screening for coeliac disease using antihuman transglutaminase antibody assay
Arch Dis Child
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England
Gut
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study
Arch Intern Med
Celiac disease: pathogenesis of a model immunogenetic disease
J Clin Invest
The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease
Eur J Gastroenterol Hepatol
Structural basis for gluten intolerance in celiac sprue
Science
Concordance, disease progression, and heritability of coeliac disease in Italian twins
Gut
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer
J Exp Med
Genetic background of celiac disease and its clinical implications
Am J Gastroenterol
Candidate gene region 2q33 in European families with coeliac disease
Tissue Antigens
Cited by (544)
Translation of cell therapies to treat autoimmune disorders
2024, Advanced Drug Delivery ReviewsImpact of probiotics on gut microbiota composition and clinical symptoms of coeliac disease patients following gluten-free diet
2023, Contemporary Clinical Trials CommunicationsMismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: A multicentric international study
2023, Digestive and Liver DiseaseDiagnostic delay in adult coeliac disease: An Italian multicentre study
2023, Digestive and Liver DiseaseCitation Excerpt :CD is characterised by proteiform manifestations, spacing from being asymptomatic to having a malabsorption syndrome. Sometimes CD may only present with isolated alterations, including osteoporosis, micronutrient deficiencies, or growth retardation making its clinical diagnosis even more challenging [1]. This broad clinical spectrum often leads to a delayed diagnosis which is associated with reduced quality of life [2,3], slow improvement of symptoms after commencing a gluten-free diet (GFD) [4,5], and increased mortality [6].
The HLA-DQ8 transgenic mouse: A model to study the immune and cytotoxic responses to wheat gliadin
2023, Methods in Cell Biology